Business Context and Reporting Period
Company: Minerva Neurosciences, Inc. (Ticker: NERV)
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2025
Reporting Period: Event date March 17, 2025; references financial data from the year ended December 31, 2024.
Key Financial Metrics
This filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report confirms that the Company demonstrated compliance with the Nasdaq Net Income Rule (Listing Rule 5550(b)(3)) based on its Annual Report on Form 10-K for the year ended December 31, 2024, which requires a minimum of $500,000 of net income from continuing operations.
Material Changes and Listing Status
- Regained Compliance: The Nasdaq Hearings Panel determined the Company has regained compliance with the Net Income Rule.
- Previous Deficiencies: The Company previously faced delisting risks due to:
- Market Value of Listed Securities falling below $35 million for 31 consecutive business days (notified April 10, 2024).
- Non-compliance with the Equity Rule (notified January 10, 2025).
- Resolution: The Panel granted continued listing through March 31, 2025, and subsequently closed the matter upon confirmation of Net Income Rule compliance.
Outlook, Risks, and Contingencies
- Monitoring Period: The Company is subject to a discretionary panel monitor for one year from March 17, 2025.
- Strict Enforcement: During the monitoring period, the Company cannot submit a plan of compliance for new deficiencies, and Nasdaq Staff cannot grant additional time to regain compliance. Failure to maintain standards will result in a Delist Determination Letter.
- Future Risk: Management states there can be no assurance the Company will maintain compliance with Nasdaq listing standards or continue its listing.
Investor Verification Checklist
- Verify the specific net income figure from continuing operations in the Form 10-K for the year ended December 31, 2024.
- Monitor the Company's stock price and Market Value of Listed Securities to ensure it remains above the $35 million threshold.
- Review upcoming quarterly reports to confirm continued adherence to the Net Income Rule during the one-year monitoring period.
- Check for any future Nasdaq correspondence regarding the Equity Rule or other listing standards.